AbbVie and Landos Biopharma have announced a definitive agreement under which AbbVie will acquire Landos, a clinical stage biopharmaceutical company focused on the development...
The European Commission (EC) has granted approval to Bristol Myers Squibb's Abecma® (idecabtagene vicleucel; ide-cel) for the treatment of adult patients with relapsed and...
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's OPSYNVI® – a single-tablet combination of macitentan, an endothelin receptor antagonist (ERA), and...